As abortion numbers climb and telehealth pills expand access, Sen. Josh Hawley pushes legislation to ban mifepristone while abortion providers call the effort politically motivated ...

What’s a shield law and how would a new bill impact patients receiving telehealth reproductive care and the providers giving ...

Mifepristone is facing another major legal challenge. For more than 25 years, this medication has been used for abortion in ...

Telehealth isn’t new, but the way it’s being used has changed a lot. What started as quick video calls for minor issues is now becoming a real part of everyday medical care. In 2026, many patients are ...

Thomas is a native of upstate New York and a graduate of the University at Albany. As a former member of CNET's How To team, he wrote about the intersection of policy, information and technology, and ...

People may use the terms telehealth and virtual care interchangeably, but they have slightly different meanings. Telehealth is a broad term that includes all forms of healthcare provided remotely ...

Add Yahoo as a preferred source to see more of our stories on Google. In the early days of the COVID-19 pandemic, President Donald Trump and Congress put into place a program that allowed people on ...

Americans age 65 and older who are insured by Medicare logged about 60 million telehealth visits annually between 2021 and 2023 – about 31 million for mental health and 29 million for other health ...

The FDA is targeting telehealth marketing of GLP-1 drugs. But those companies may not be the only ones under the microscope.

New York, March 11, 2026 -- Zealthy’s is pleased to announce its comprehensive telehealth platform. The new service enables physician-supervised GLP-1 weight loss programs, mental health care, ...

Telehealth beats e-commerce with recurring revenue and higher margins. Less competition and strong demand make telehealth a profitable opportunity. Launching a telehealth brand is now as easy as ...

The FDA has issued warnings to 30 telehealth companies for making false or misleading claims regarding compounded GLP-1 ...